Drugs / NYVAC Nat-B env vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01970449 | ? → Aug 2018 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NYVAC Nat-B env vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01970449 ↗ |
| Modality | Vaccine | “NYVAC Nat-B env vaccine injections” NCT01970449 ↗ |
| Route | Intramuscular | “3 × 10\^7 plaque forming units (pfu) dose IM” NCT01970449 ↗ |